Results are from company’s phase 2 head and neck cancer trial with lead NOX inhibitor candidate

Facility will deliver technology to scientists, helping them to translate genomic insights

Leprosy has existed since at least Biblical times, yet scientists still don’t know exactly how Mycobacterium leprae causes […]

Cancer therapies that target specific genetic abnormalities in tumors have revolutionized treatment possibilities over the past two decades. […]

The global market for artificial intelligence (AI) for healthcare is booming. Currently valued at $15bn (£12bn; €14bn), it […]

The company aims to deliver therapies that provide benefits to patients affected by eye diseases

Company adds a number of additional brands from Sanofi following initial take overs in 2021

The World Health Organization lists bacteria that are resistant to antibiotics as one of the top 10 global […]

The UK government’s Levelling Up white paper,1 and the Levelling Up and Regeneration Bill set out aims on […]

Clinicians should consider the use of intramuscular injections for people with vitamin B12 deficiency when there are concerns […]